Integrative analysis identifies an older female-linked AML patient group with better risk in ECOG-ACRIN Cancer Research Group's clinical trial E3999

Files
Rapaport2022Integrative-CCBY.pdf (994.65 KB)
Date
2022-09-23
Authors
Rapaport, Franck
Seier, Kenneth
Neelamraju, Yaseswini
Hassane, Duane
Baslan, Timour
Gildea, Daniel T.
Haddox, Samuel
Lee, Tak
Murdock, H. Moses
Sheridan, Caroline
Thurmond, Alexis
Wang, Ling
Carroll, Martin
Cripe, Larry D.
Fernandez, Hugo
Mason, Christopher E.
Paietta, Elisabeth
Roboz, Gail J.
Sun, Zhuoxin
Tallman, Martin S.
Zhang, Yanming
Gönen, Mithat
Levine, Ross
Melnick, Ari M.
Kleppe, Maria
Garrett-Bakelman, Francine E.
Language
American English
Embargo Lift Date
Department
Medicine, School of Medicine
Committee Members
Degree
Degree Year
Department
Grantor
Journal Title
Journal ISSN
Volume Title
Found At
Springer Nature
Abstract
Description
Keywords
Acute myeloid leukemia, Cancer genetics, Cytogenetics
item.page.description.tableofcontents
item.page.relation.haspart
Cite As
Rapaport F, Seier K, Neelamraju Y, et al. Integrative analysis identifies an older female-linked AML patient group with better risk in ECOG-ACRIN Cancer Research Group's clinical trial E3999 [published correction appears in Blood Cancer J. 2023 Jul 6;13(1):103]. Blood Cancer J. 2022;12(9):137. Published 2022 Sep 23. doi:10.1038/s41408-022-00736-z
ISSN
Publisher
Series/Report
Sponsorship
Major
Extent
Identifier
Relation
Journal
Blood Cancer Journal
Rights
Attribution 4.0 International Creative Commons licenses
Source
PMC
Alternative Title
Type
Article
Number
Volume
Conference Dates
Conference Host
Conference Location
Conference Name
Conference Panel
Conference Secretariat Location
Permanent Link
https://hdl.handle.net/1805/41204
DOI
https://doi.org/10.1038/s41408-022-00736-z
Version
Final published version
Full Text Available at
This item is under embargo {{howLong}}
Collections
Open Access Policy Articles